Selected experience includes:

Mergers & Acquisitions

Shionogi & Co, Ltd. on its strategic investment in connection with a joint research and development agreement with Salubritas Therapeutics.

Zuellig Pharma on its acquisition of Cialis and Alimta from Eli Lilly for eight ASEAN markets.

Versanis Bio on its acquisition by Eli Lilly and Company for up to $1.925 billion. Haystack Oncology on its acquisition by Quest Diagnostics for up to $450 million.

Vaccitech plc on its acquisition of Avidea Technologies, Inc. for approximately $40 million in cash and equity, plus potential payments upon achievement of milestones.

Thrive Earlier Detection Corp. on its acquisition by Exact Sciences Corporation for up to $2.15 billion.

Unum Therapeutics on the sale of its BOXR (Bolt-on Chimeric Receptor) technology for approximately $11.5 million.

Unum Therapeutics on its acquisition of KIQ LLC and concurrent PIPE investment to raise $104 million.

Avadel Legacy Pharmaceuticals, a wholly owned subsidiary of Avadel Pharmaceuticals (Ireland), on the sale of its hospital product assets for approximately $40 million.

Alnylam Pharmaceuticals on a $100 million equity financing closed in connection with its $2 billion strategic financing collaboration with Blackstone.

CRISPR Therapeutics on a series of transactions by which CRISPR acquired 100% of the partnership interests of Casebia Therapeutics.

BeiGene on its $2.7 billion share sale as part of a global strategic collaboration with Amgen.

BlueRock Therapeutics on its acquisition by Bayer AG for up to $1 billion.

Ultragenyx Pharmaceuticals Inc. on its partnership with GeneTx Biotherapeutics LLC to develop GeneTx's GTX-102.

A global provider of digital communication services on its $640 million going-private transaction.

A global provider of telecom products and services on its $272 million sale of assets involving operations and employees in over 20 countries.

A public business software company on its $600 million stock-for-stock acquisition by another global public company in the electronic business solutions industry.

A national transportation company in connection with multiple business acquisitions.

Venture Financings

Beta Bionics on its $63 million Series B2 financing and its $57 Series C financing.

Versanis Bio on its $70 million Series A financing.

OrbiMed as co-lead investor on the $40 million Series A financing of Gennao Bio.

Amylyx Pharmaceuticals on its $135 million Series C financing.

Karuna Therapeutics on its $82 million Series B financing.

Thrive Earlier Detection Corp. on its $110 million Series A financing.

Capital Markets

AlloVir on its $317.7 million IPO, $100 million at-the-market offering, $126.6 million registered direct offering, and $75 million follow-on public offering.

Cerevel Therapeutics on its $350 million follow-on public offering, $600 million public offering of common stock and concurrent private placement of 144A convertible senior notes, and $250 million at-the-market offering.

Esperion Therapeutics on its $280 million 144A offering, $250 million at-the-market offering, $225 million follow-on public offering, and $57 million registered direct offering.

Karuna Therapeutics on its $100 million IPO, $250 million and $287.5 million follow-on public offerings, and $150 million at-the-market offering.

Bluebird bio on its $75 million private placement financing in connection with its spinout of 2seventy bio.

Kymera Therapeutics on its $257 million follow-on public offering.Advised Unilever PLC on its acquisition of Liquid IV, a US-based health science nutrition and wellness company.

Pro Bono

Serving a member of the Board of Directors for the March of Dimes Boston chapter.

Assisting individuals on citizenship and immigration matters, including bond hearings and asylum applications.

Representing a petitioner seeking clemency through the Federal Clemency Project.

Advising veterans of Operation Iraqi Freedom and Operation Enduring Freedom in applying for Combat-Related Special Compensation (CRSC).

*Certain matters were worked on prior to joining White & Case.